查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1293632

抗生素市场：按作用机制、药物类别和作用范围 - 俄罗斯-乌克兰衝突和高通胀 - 2023-2030 年全球预测

Antibiotics Market by Action Mechanism, Drug Class, Spectrum - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球抗生素市场预计将大幅增长，2023年将达到420.6亿美元，2030年将达到653.7亿美元，复合年增长率为6.47%。

FPNV定位矩阵

FPNV定位矩阵对于评估全球抗生素市场至关重要。 通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的决策。 这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场区域的当前状态。 比较供应商对整体收入、客户群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。 该分析还揭示了特定行业的竞争程度、积累和分散的优势以及研究基准年的併购特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要公司所服务的市场的全面信息。

2. 市场开发：提供有关利润丰厚的新兴市场的详细信息，并分析其在成熟市场领域的渗透率。

3. 市场多元化：提供有关新产品发布、未开发地区、最新开发和投资的详细信息。

4.市场趋势：全面了解俄罗斯-乌克兰衝突和高通胀。

5.竞争评估与信息：对各大公司的市场份额、战略、产品、认证、监管状况、专利状况、製造能力进行综合评估。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

此报告回答了以下问题：

1.全球抗生素市场规模及预测是多少？

2. 在预测期内，COVID-19 对全球抗生素市场的抑制因素和影响是什么？

3. 在预测期内，全球抗生素市场需要投资哪些产品/细分市场/应用/领域？

4.全球抗生素市场的竞争策略是什么？

5.全球抗生素市场的技术趋势和监管框架是什么？

6.全球抗生素市场主要厂商的市场份额是多少？

7.什么形式和战略举措被认为适合进入全球抗生素市场？

目录

第一章前言

第二章研究方法

第 3 章执行摘要

第四章市场概述

第 5 章市场洞察

  • 市场动态
    • 促进因素
      • 传染病患者增加
      • 为众多临床试验开发新抗生素和新策略
      • 中低收入国家的消费增加
    • 抑制因素
      • 滥用抗生素
    • 机会
      • 用于治疗抗生素耐药微生物感染的先进有前景分子和新型联合疗法
      • 新药研发和投资不断扩大
    • 作业
      • 使用抗生素引起的副作用
  • 市场趋势
  • 新冠肺炎 (COVID-19) 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通胀的累积影响
  • 波特五力分析
  • 价值炼和关键路径分析
  • 监管框架
  • 客户定制

第 6 章抗生素市场：按作用机制

  • 简介
  • 细胞壁合成抑製剂
  • DNA合成抑製剂
  • 霉菌酸抑製剂
  • 蛋白质合成抑製剂
  • RNA合成抑製剂

第 7 章抗生素市场：按药物类别

  • 简介
  • 氨基糖甘类
  • 碳青霉烯类
  • 头孢菌素类
  • 氟奎诺酮类药物
  • 大环内酯类
  • 青霉素
  • 磺□胺

第 8 章抗生素市场：按药效范围划分

  • 简介
  • 广谱抗生素
  • 窄谱抗生素

第九章北美和南美抗生素市场

  • 简介
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区抗生素市场

  • 简介
  • 澳大利亚
  • 中国
  • 印度
  • 印度尼西亚
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲抗生素市场

  • 简介
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 意大利
  • 荷兰
  • 尼日利亚
  • 挪威
  • 波兰
  • 卡塔尔
  • 俄罗斯
  • 沙特阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯联合酋长国
  • 英国

第十二章竞争态势

  • FPNV定位矩阵
  • 市场份额分析：按主要公司划分
  • 竞争情景分析：主要公司

第十三章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可证和价格
Product Code: MRR-434CCDA05131

The Global Antibiotics Market is forecasted to grow significantly, with a projected USD 42.06 billion in 2023 at a CAGR of 6.47% and expected to reach a staggering USD 65.37 billion by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Antibiotics Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Antibiotics Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Action Mechanism, market is studied across Cell Wall Synthesis Inhibitors, DNA Synthesis Inhibitors, Mycolic Acid Inhibitors, Protein Synthesis Inhibitors, and RNA Synthesis Inhibitors. The Mycolic Acid Inhibitors is projected to witness significant market share during forecast period.

Based on Drug Class, market is studied across Aminoglycosides, Carbapenem, Cephalosporin, Fluoroquinolone, Macrolides, Penicillin, and Sulfonamides. The Fluoroquinolone is projected to witness significant market share during forecast period.

Based on Spectrum, market is studied across Broad-spectrum Antibiotics and Narrow-spectrum Antibiotics. The Broad-spectrum Antibiotics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific commanded largest market share of 38.10% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Antibiotics Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Antibiotics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Antibiotics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Antibiotics Market?

4. What is the competitive strategic window for opportunities in the Global Antibiotics Market?

5. What are the technology trends and regulatory frameworks in the Global Antibiotics Market?

6. What is the market share of the leading vendors in the Global Antibiotics Market?

7. What modes and strategic moves are considered suitable for entering the Global Antibiotics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Antibiotics Market, by Action Mechanism, 2022 vs 2030
  • 4.3. Antibiotics Market, by Drug Class, 2022 vs 2030
  • 4.4. Antibiotics Market, by Spectrum, 2022 vs 2030
  • 4.5. Antibiotics Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Patients Suffering from Infectious Diseases
      • 5.1.1.2. Development of Novel Strategies for New Antibiotics and a Large Number of Clinical Trials
      • 5.1.1.3. Extended Consumption in Low and Middle-Income Countries
    • 5.1.2. Restraints
      • 5.1.2.1. Misuse of Antibiotics
    • 5.1.3. Opportunities
      • 5.1.3.1. Advanced Prospect Molecules and Novel Combination Therapies to Treat Antibiotic-Resistant Microbial Infections
      • 5.1.3.2. Growing in R&D and Investments for New Drugs
    • 5.1.4. Challenges
      • 5.1.4.1. Side Effects Caused by the Usage of Antibiotic Drugs
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Antibiotics Market, by Action Mechanism

  • 6.1. Introduction
  • 6.2. Cell Wall Synthesis Inhibitors
  • 6.3. DNA Synthesis Inhibitors
  • 6.4. Mycolic Acid Inhibitors
  • 6.5. Protein Synthesis Inhibitors
  • 6.6. RNA Synthesis Inhibitors

7. Antibiotics Market, by Drug Class

  • 7.1. Introduction
  • 7.2. Aminoglycosides
  • 7.3. Carbapenem
  • 7.4. Cephalosporin
  • 7.5. Fluoroquinolone
  • 7.6. Macrolides
  • 7.7. Penicillin
  • 7.8. Sulfonamides

8. Antibiotics Market, by Spectrum

  • 8.1. Introduction
  • 8.2. Broad-spectrum Antibiotics
  • 8.3. Narrow-spectrum Antibiotics

9. Americas Antibiotics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Antibiotics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Antibiotics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

1. Abbott Laboratories

2. Akron Incorporated

3. Amneal Pharmaceuticals LLC

4. Astellas Pharma, Inc.

5. Bausch Health Companies, Inc.

6. Bayer AG

7. Bristol-Myers Squibb Company

8. Cadila Healthcare Ltd.

9. Eli Lilly and Company

10. F. Hoffmann-La Roche AG

11. Johnson & Johnson

12. KYORIN Holdings, Inc.

13. LG Chem Ltd.

14. Lupin Limited

15. Melinta Therapeutics, Inc.

16. Merck & Co., Inc.

17. MerLion Pharmaceuticals GmbH

18. Mylan N.V.

19. Novartis International AG

20. Pfizer Inc.

21. Sanofi S.A.

22. Shionogi & Co., Ltd.

23. Sun Pharmaceutical Industries Limited

24. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. ANTIBIOTICS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIBIOTICS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2022 VS 2030 (%)
  • FIGURE 5. ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2022 VS 2030 (%)
  • FIGURE 6. ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2022 VS 2030 (%)
  • FIGURE 7. ANTIBIOTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. ANTIBIOTICS MARKET DYNAMICS
  • FIGURE 9. ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 5. ANTIBIOTICS MARKET SIZE, BY CELL WALL SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIBIOTICS MARKET SIZE, BY DNA SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. ANTIBIOTICS MARKET SIZE, BY MYCOLIC ACID INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. ANTIBIOTICS MARKET SIZE, BY PROTEIN SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. ANTIBIOTICS MARKET SIZE, BY RNA SYNTHESIS INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 11. ANTIBIOTICS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. ANTIBIOTICS MARKET SIZE, BY CARBAPENEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. ANTIBIOTICS MARKET SIZE, BY FLUOROQUINOLONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. ANTIBIOTICS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. ANTIBIOTICS MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. ANTIBIOTICS MARKET SIZE, BY SULFONAMIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 19. ANTIBIOTICS MARKET SIZE, BY BROAD-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. ANTIBIOTICS MARKET SIZE, BY NARROW-SPECTRUM ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY ACTION MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM ANTIBIOTICS MARKET SIZE, BY SPECTRUM, 2018-2030 (USD MILLION)
  • TABLE 148. ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 149. ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 150. ANTIBIOTICS MARKET LICENSE & PRICING